Publications by authors named "G Revon-Riviere"
Impact of the COVID-19 Pandemic Onset on the Early Careers of Pediatric Oncology Health Professionals and Researchers: A Report From the Children's Oncology Group Young Investigators Committee, Young SIOP Network, and Young SIOPE.
Gemma Bryan Louise Guolla Gabriela Inés Villanueva Sarah Cohen-Gogo Alejandra Casanovas Gabriel Revon-Riviere
Pediatr Blood Cancer
January 2025
Article Synopsis
- The COVID-19 pandemic severely affected early-career pediatric oncology professionals, impacting their work practices, productivity, and career development.
- A survey conducted in 2021 with 499 participants from 48 countries revealed that many experienced job insecurity, decreased academic productivity, and reduced career opportunities, especially among women and individuals with childcare responsibilities.
- The findings emphasize the need for governing bodies to address and support the unique challenges faced by these professionals during the pandemic.
Article Synopsis
- Spinal cord compression (SCC) is a critical issue in kids with advanced cancers, prompting a study on its presentation and treatment options, especially focusing on radiation therapy.
- A retrospective review of 28 patients revealed 34 cases of SCC, with neuroblastoma being the most common cancer; both preemptive and reactive treatments showed similar outcomes in survival and quality of life.
- The study suggests that proactive radiation therapy may not offer significantly better results than reactive approaches, indicating that treatment decisions should be personalized and more research is needed for better strategies in pediatric cancer care.
Article Synopsis
- - The Ewing Sarcoma Family of Tumors (ESFT) includes rare cancers, with a significant portion showing metastatic spread, especially affecting bone and bone marrow, which worsens prognosis and necessitates stronger treatments.
- - The French phase II COMBINAIR3 study compared the effectiveness of PET/CT to traditional bone marrow aspiration and biopsy (BMAB) for staging extra-pulmonary metastatic ESFT in 42 patients.
- - Results indicated that PET/CT had high specificity (100%) and notable sensitivity (83.3%) in detecting bone marrow involvement, suggesting it can replace BMAB for initial staging, thereby enhancing treatment planning for high-risk ESFT patients.